Karyopharm Therapeutics, Inc (KPTI) Covered Calls

Karyopharm Therapeutics, Inc covered calls Karyopharm Therapeutics Inc., is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.

You can sell covered calls on Karyopharm Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for KPTI (prices last updated Fri 4:16 PM ET):

Karyopharm Therapeutics, Inc (KPTI) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
9.62 -0.19 9.50 11.65 446K - 0.0B
Covered Calls For Karyopharm Therapeutics, Inc (KPTI)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 10 0.30 11.35 -11.9% -542.9%
Jan 18 10 0.65 11.00 -9.1% -92.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. Its selective inhibitors of nuclear export compounds function by preventing the export of tumor suppressor proteins from the nucleus of a cell. Karyopharm Therapeutics was founded by Joseph Araujo, Ronald A. DePinho, Pamela A Silver, Giulio Draetta, Michael G. Kauffman and Sharon Shacham on December 22, 2008 and is headquartered in Newton, MA.